Bristol-Myers Squibb has won FDA approval for the first LAG-3 inhibitor drug ahead of its rivals in cancer immunotherapy, including Merck & Co. The US regulator cleared BMS' LAG-3 drug relatlimab as a ...

Those with AI skills are said to make more, but how much more? Also, how have our actual experts been using AI in their own ...

Variable names are alphanumeric but must start with a letter. The length of a variable name is limited to thirty-two characters for non-SAS data set variables Model variables are declared by VAR, ...

The move is aimed at preventing misuse of market data while ensuring that educational content remains useful and relevant for ...